| 1 | 17609160 | SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells. | J Biosci Bioeng | 2007 May |
2 |
| 2 | 23752591 | The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy. | Genes Dev | 2013 Jun 1 |
2 |
| 3 | 26985287 | Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor. | ACS Med Chem Lett | 2016 Feb 11 |
5 |
| 4 | 31968646 | Chitooligosaccharides Modulate Glucose-Lipid Metabolism by Suppressing SMYD3 Pathways and Regulating Gut Microflora. | Mar Drugs | 2020 Jan 20 |
3 |
| 5 | 32934676 | SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis. | Exp Ther Med | 2020 Nov |
2 |
| 6 | 33244033 | Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase. | Sci Rep | 2020 Nov 26 |
2 |
| 7 | 34587977 | Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. | J Exp Clin Cancer Res | 2021 Sep 29 |
2 |